Italia Markets open in 6 hrs 14 mins

PCI Biotech Holding ASA (0JGL.L)

LSE - LSE Prezzo differito. Valuta in NOK.
Aggiungi a watchlist
2,8200+0,2300 (+8,88%)
Alla chiusura: 08:05AM GMT
Schermo intero
Chiusura precedente2,5900
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Media VolumeN/D
Beta (5 anni mensile)1,69
Rapporto PE (ttm)N/D
EPS (ttm)-2,3480
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing

    Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The partners have signed a collaborative research agreement with the purpose of testing PCI Biotech’s proprietary technology for gene therapy manufacturing in the partners’ pilot manufacturing process. PCI Biotech brings its novel and promising technology for viral vector manufacturing into the field testin

  • GlobeNewswire

    PCI Biotech: European patent for mRNA delivery with fimaNAc

    Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech that they intend to grant a new patent covering delivery of mRNA by use of PCI Biotech’s fimaNAc technology. This application is primarily foreseen to be used for dermatology. Nucleic acid therapeutics, including mRNAs, have the potential to improve the treatment of dermatological diseases, but delivery to skin lesions remains an o

  • GlobeNewswire

    PCI Biotech: Employee share option scheme

    Oslo, 4 September 2023 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the Annual General Meeting 25 May 2023 and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 700,000 share options to key employees. Each share option gives the right to subscribe for or acquire one sh